NuScale started with Sell equivalent at Wedbush; Oklo, X-Energy, NANO rated Outperform

What happened

Wedbush began covering nuclear technology firms on Tuesday, rating NuScale Power Underperform with a $5 price target while starting Oklo, X-Energy and NANO Nuclear at Outperform with $36, $17 and $18 price targets respectively.

Confirmed

Global impact / market context

Broker ratings can steer investor money toward or away from these nuclear developers, which need funding to build reactors. A poor NuScale rating may raise its cost of raising cash and pressure its shares, while Outperform ratings may help rivals attract investors.

Analyst inference

Wedbush's split view places NuScale apart from peers because it has no binding financed module order in 19 years and relies on partner ENTRA1 for orders, while Oklo's reactor progress and platform are cited as strengths. This frames advanced nuclear as a stock-picking sector.

Analyst inference

What to watch

1. NuScale's lack of a binding, financed module order and its reliance on ENTRA1, which the analyst says has no history of financing, developing or operating generation assets, remain central facts. Confirmed
2. Watch whether NuScale signs a binding, financed module order and whether ENTRA1 proves it can fund and execute projects, which would test Wedbush's Underperform view. Proposed
3. Track Oklo's progress on its three-segment platform and whether its Groves test reactor milestone translates into commercial orders, orders that could support its Outperform rating. Analyst inference

Evidence

• seekingalpha.com